NO20013673L - Acetyleniske bicykliske orto-sulfonamido -og fosfinsyreamidoheteroarylhydroksamsyrer som TACE-inhibitorer - Google Patents
Acetyleniske bicykliske orto-sulfonamido -og fosfinsyreamidoheteroarylhydroksamsyrer som TACE-inhibitorerInfo
- Publication number
- NO20013673L NO20013673L NO20013673A NO20013673A NO20013673L NO 20013673 L NO20013673 L NO 20013673L NO 20013673 A NO20013673 A NO 20013673A NO 20013673 A NO20013673 A NO 20013673A NO 20013673 L NO20013673 L NO 20013673L
- Authority
- NO
- Norway
- Prior art keywords
- orthosulfonamido
- acetylenic
- bicyclic
- phosphinic acid
- hydroxamic acids
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
- C07C309/01—Sulfonic acids
- C07C309/28—Sulfonic acids having sulfo groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
- C07C309/41—Sulfonic acids having sulfo groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing singly-bound oxygen atoms bound to the carbon skeleton
- C07C309/42—Sulfonic acids having sulfo groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing singly-bound oxygen atoms bound to the carbon skeleton having the sulfo groups bound to carbon atoms of non-condensed six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
- C07C309/78—Halides of sulfonic acids
- C07C309/86—Halides of sulfonic acids having halosulfonyl groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
- C07C309/87—Halides of sulfonic acids having halosulfonyl groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing singly-bound oxygen atoms bound to the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
- C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Diabetes (AREA)
- Rheumatology (AREA)
- Virology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Emergency Medicine (AREA)
- Obesity (AREA)
- Tropical Medicine & Parasitology (AREA)
- AIDS & HIV (AREA)
- Hospice & Palliative Care (AREA)
- Endocrinology (AREA)
- Transplantation (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Molecular Biology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Quinoline Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US23908499A | 1999-01-27 | 1999-01-27 | |
PCT/US2000/002144 WO2000044749A1 (en) | 1999-01-27 | 2000-01-27 | Acetylenic ortho-sulfonamido and phosphinic acid amido bicyclic heteroaryl hydroxamic acids as tace inhibitors |
Publications (2)
Publication Number | Publication Date |
---|---|
NO20013673D0 NO20013673D0 (no) | 2001-07-26 |
NO20013673L true NO20013673L (no) | 2001-09-21 |
Family
ID=22900535
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20013673A NO20013673L (no) | 1999-01-27 | 2001-07-26 | Acetyleniske bicykliske orto-sulfonamido -og fosfinsyreamidoheteroarylhydroksamsyrer som TACE-inhibitorer |
Country Status (22)
Country | Link |
---|---|
EP (2) | EP1279674A3 (de) |
JP (1) | JP2002535404A (de) |
KR (1) | KR20010101690A (de) |
CN (1) | CN1207294C (de) |
AR (1) | AR022424A1 (de) |
AT (1) | ATE227288T1 (de) |
AU (1) | AU2741800A (de) |
BR (1) | BR0007760A (de) |
CA (1) | CA2355735A1 (de) |
CZ (1) | CZ20012721A3 (de) |
DE (1) | DE60000724T2 (de) |
DK (1) | DK1157024T3 (de) |
EA (1) | EA200100814A1 (de) |
ES (1) | ES2186628T3 (de) |
HK (1) | HK1038562B (de) |
HU (1) | HUP0105307A3 (de) |
IL (1) | IL144291A0 (de) |
NO (1) | NO20013673L (de) |
PL (1) | PL349070A1 (de) |
PT (1) | PT1157024E (de) |
WO (1) | WO2000044749A1 (de) |
ZA (1) | ZA200104324B (de) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2005021489A2 (en) | 2002-12-23 | 2005-03-10 | Wyeth Holdings Corporation | Acetylenic aryl sulfonate hydroxamic acid tace and matrix metalloproteinase inhibitors |
EP1449538A1 (de) | 2003-02-21 | 2004-08-25 | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. | Modulation der EGF Rezeptor Signalübertragung durch Hemmung von TACE oder Amphiregulin |
WO2004110454A1 (ja) * | 2003-06-13 | 2004-12-23 | Ishihara Sangyo Kaisha, Ltd. | アデノシンA2a受容体アゴニストの投与が必要な疾患を治療又は予防するための組成物 |
EP2170884A2 (de) * | 2007-06-25 | 2010-04-07 | Boehringer Ingelheim International GmbH | Chemische verbindungen |
EP3860608A1 (de) | 2018-10-04 | 2021-08-11 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Egfr-inhibitoren zur behandlung von keratosen |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE229949T1 (de) * | 1996-10-16 | 2003-01-15 | American Cyanamid Co | Herstellung und verwendung von ortho-sulfonamido- heteroarylhydroxamsäuren als matrix- metalloproteinase und tace inhibitoren |
AU743901B2 (en) * | 1996-10-16 | 2002-02-07 | Wyeth Holdings Corporation | Ortho-sulfonamido bicyclic heteroaryl hydroxamic acids as matrix metalloprote inase and tace inhibitors |
-
2000
- 2000-01-26 AR ARP000100324A patent/AR022424A1/es unknown
- 2000-01-27 EA EA200100814A patent/EA200100814A1/ru unknown
- 2000-01-27 EP EP02024564A patent/EP1279674A3/de not_active Withdrawn
- 2000-01-27 KR KR1020017009364A patent/KR20010101690A/ko not_active Application Discontinuation
- 2000-01-27 HU HU0105307A patent/HUP0105307A3/hu unknown
- 2000-01-27 IL IL14429100A patent/IL144291A0/xx unknown
- 2000-01-27 AU AU27418/00A patent/AU2741800A/en not_active Abandoned
- 2000-01-27 DE DE60000724T patent/DE60000724T2/de not_active Expired - Fee Related
- 2000-01-27 JP JP2000596005A patent/JP2002535404A/ja active Pending
- 2000-01-27 PL PL00349070A patent/PL349070A1/xx not_active Application Discontinuation
- 2000-01-27 DK DK00905788T patent/DK1157024T3/da active
- 2000-01-27 WO PCT/US2000/002144 patent/WO2000044749A1/en not_active Application Discontinuation
- 2000-01-27 CA CA002355735A patent/CA2355735A1/en not_active Abandoned
- 2000-01-27 CZ CZ20012721A patent/CZ20012721A3/cs unknown
- 2000-01-27 CN CNB008030294A patent/CN1207294C/zh not_active Expired - Fee Related
- 2000-01-27 ES ES00905788T patent/ES2186628T3/es not_active Expired - Lifetime
- 2000-01-27 PT PT00905788T patent/PT1157024E/pt unknown
- 2000-01-27 BR BR0007760-7A patent/BR0007760A/pt not_active IP Right Cessation
- 2000-01-27 EP EP00905788A patent/EP1157024B1/de not_active Expired - Lifetime
- 2000-01-27 AT AT00905788T patent/ATE227288T1/de not_active IP Right Cessation
-
2001
- 2001-05-25 ZA ZA200104324A patent/ZA200104324B/en unknown
- 2001-07-26 NO NO20013673A patent/NO20013673L/no not_active Application Discontinuation
-
2002
- 2002-01-08 HK HK02100116.7A patent/HK1038562B/zh not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
EP1157024A1 (de) | 2001-11-28 |
KR20010101690A (ko) | 2001-11-14 |
PT1157024E (pt) | 2003-02-28 |
NO20013673D0 (no) | 2001-07-26 |
HUP0105307A3 (en) | 2002-10-28 |
CZ20012721A3 (cs) | 2002-03-13 |
BR0007760A (pt) | 2001-11-13 |
CA2355735A1 (en) | 2000-08-03 |
ZA200104324B (en) | 2002-08-26 |
AU2741800A (en) | 2000-08-18 |
ATE227288T1 (de) | 2002-11-15 |
JP2002535404A (ja) | 2002-10-22 |
CN1337962A (zh) | 2002-02-27 |
DE60000724T2 (de) | 2003-08-21 |
HUP0105307A2 (hu) | 2002-05-29 |
CN1207294C (zh) | 2005-06-22 |
PL349070A1 (en) | 2002-07-01 |
IL144291A0 (en) | 2002-05-23 |
EA200100814A1 (ru) | 2001-12-24 |
HK1038562A1 (en) | 2002-03-22 |
AR022424A1 (es) | 2002-09-04 |
DK1157024T3 (da) | 2003-03-03 |
HK1038562B (zh) | 2003-02-21 |
EP1279674A3 (de) | 2003-10-01 |
ES2186628T3 (es) | 2003-05-16 |
WO2000044749A1 (en) | 2000-08-03 |
EP1157024B1 (de) | 2002-11-06 |
EP1279674A2 (de) | 2003-01-29 |
DE60000724D1 (en) | 2002-12-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK1144368T3 (da) | Acetyleniske alfa-aminosyrebaserede sulfonamid-hydroxamsyre-TACE-inhibitorer | |
DK0925303T3 (da) | Phosphinsyreamider som matrixmetalloproteaseinhibitorer | |
NO20010686D0 (no) | Hydroksypipecolathydroksaminsyrederivater som MMP inhibitorer | |
DK1036062T3 (da) | Hydroxamsyrederivater som matrix metalloprotease (MMP) inhibitorer | |
AU4692399A (en) | Cyclic hydroxamic acids as metalloproteinase inhibitors | |
DK0938471T3 (da) | Fremstillingen og anvendelsen af ortho-sulfonamido-arylhydroxamsyrer som matrix-metalloproteinase- og TACE-inhibitorer | |
NO20043102L (no) | Fjerning av sure gasser | |
EE200100410A (et) | Sulfamaathüdroksaamhappe metalloproteaasi inhibiitor | |
DK1147080T3 (da) | Alkynylholdige hydroxamsyreforbindelser som TACE-inhibitorer | |
NO20013673D0 (no) | Acetyleniske bicykliske orto-sulfonamido -og fosfinsyreamidoheteroarylhydroksamsyrer som TACE-inhibitorer | |
NO20024481D0 (no) | Difluorbutyrsyre metalloproteaseinhibitorer | |
EE04750B1 (et) | HIV-proteaasi inhibiitorite valmistamismeetod | |
NO20013639D0 (no) | Acetyleniske <beta>-sulfonamido- og -fosfinsyreamid- hydroksamsyre-TACE-inhibitorer | |
EE200100084A (xx) | NOS inhibiitorite uued farmatseutilised kasutusv�imalused | |
DK1147102T3 (da) | Heteroaryl-acetyleniske sulfonamid- og phosphinsyreamid-hydroxamsyre-TACE-inhibitorer | |
SI1157024T1 (en) | Acetylenic ortho-sulfonamido and phosphinic acid amido bicyclic heteroaryl hydroxamic acids as tace inhibitors | |
NO20011654D0 (no) | Benzamidderivater som trombininhibitorer | |
SI1144368T1 (en) | Acetylenic alpha-amino acid-based sulfonamide hydroxamic acid tace inhibitors |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |